Current Status and Growth of Nuclear Theranostics in Singapore

The concept of theranostics, where individual patient-level biological information is used to choose the optimal therapy for that individual, has become more popular in the modern era of ‘personalised’ medicine. With the growth of theranostics, nuclear medicine as a specialty is uniquely poised to g...

Full description

Saved in:
Bibliographic Details
Published inNuclear medicine and molecular imaging Vol. 53; no. 2; pp. 96 - 101
Main Authors Huang, Hian Liang, Tong, Aaron Kian Ti, Thang, Sue Ping, Yan, Sean Xuexian, Lam, Winnie Wing Chuen, Loke, Kelvin Siu Hoong, Tang, Charlene Yu Lin, Cheng, Lenith Tai Jit, Ooi, Gideon Su Kai, Low, Han Chung, Magsombol, Butch Maulion, Tham, Wei Ying, Goh, Charles Xian Yang, Tan, Colin Jingxian, Khor, Yiu Ming, Zaheer, Sumbul, Bharadwaj, Pushan, Xie, Wanying, Ng, David Chee Eng
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.04.2019
Springer Nature B.V
대한핵의학회
Subjects
Cardiology
Imaging
Iodine 131
Medicine
Medicine & Public Health
Nuclear Medicine
Oncology
Orthopedics
Perspective
Prostate
Radiation therapy
Radioisotopes
Radiology
Radium
Yttrium
Yttrium isotopes
방사선과학
Singapore
Radioiodine
Singapore
Yttrium
Lutetium
Theranostic
Radium
Online AccessGet full text

Cover

More Information
Summary:The concept of theranostics, where individual patient-level biological information is used to choose the optimal therapy for that individual, has become more popular in the modern era of ‘personalised’ medicine. With the growth of theranostics, nuclear medicine as a specialty is uniquely poised to grow along with the ever-increasing number of concepts combining imaging and therapy. This special report summarises the status and growth of Theranostic Nuclear Medicine in Singapore. We will cover our experience with the use of radioiodine, radioiodinated metaiodobenzylguanidine, peptide receptor radionuclide therapy, prostate specific membrane antigen radioligand therapy, radium-223 and yttrium-90 selective internal radiation therapy. We also include a section on our radiopharmacy laboratory, crucial to our implementation of theranostic principles. Radionuclide theranostics has seen tremendous growth and we hope to be able to grow alongside to continue to serve the patients in Singapore and in the region.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1869-3474
1869-3482
DOI:10.1007/s13139-019-00580-3